10
Treatment
IB2 and IIA2 If chemotherapy is
available, use NACT
followed by extrafascial
hysterectomy; if
chemotherapy is not
available, extrafascial
hysterectomy
(modification as deemed
necessary) may be
performed if the surgical
capacity is present
(CB, L, W)
If chemotherapy is available,
NACT followed by radical
hysterectomy (see Note) plus
PLND ± para-aortic LN
sampling may be an option
d,f
(EB, I, M)
If EBRT is available, but not
brachytherapy, then chemoRT
followed by extrafascial
hysterectomy or RT (if
chemotherapy not available)
followed by extrafascial
hysterectomy (see Note)
(CB, L, W)
OR if no EBRT is available,
then brachytherapy and
concurrent low-dose platinum-
based chemotherapy followed
by radical hysterectomy (see
Note)
f
When brachytherapy is not
available, extrafascial or radical
hysterectomy is recommended
only when there is persistent
central pelvic disease and
selective lymphadenectomy
or LN biopsy for suspicious
lesions
(EB/CB, L-I, W-M)
Radical hysterectomy plus
PLND ± para-aortic LN
sampling
(EB, L, W)
Table 3. Recommendations for Stage IA, IB, and IIA Disease
(cont'd)
Type of Disease Basic Limited
